April 11, 2013 — A new oral diabetes drug is expected to arrive on pharmacy shelves in the U.S. this week. Many people predict that Invokana (canagliflozin), approved by the FDA in March, will be a brisk seller. That's partly because it treats type 2

[click to continue…]

(April 8, 2013) – On the heels of the recent HDR TMK merger, HDR TMK has been selected to design its first science + technology project in Europe?the Center of Integrated Diabetes Research at the Helmholtz Center in Munich.

[click to continue…]

American Diabetes Association Aims To Raise Awareness About Disease With Tour De Cure Cycling Race

April 13, 2013

As a teen, Jim Caldwell raced down Boulder, Co. hills on a bicycle that cost more than his first car, relishing the rush of wind against his face. Now, years later, Caldwell, 61, returned to cycling to control his Type 2 diabetes and raise awareness about the disease.

Read the full article →

Diabetes And Melatonin

April 13, 2013

A person's sleep-wake cycle is an environmental factor that contributes to the risk of diabetes. It has been shown that people on changing shift work have an increased incidence of diabetes. “Now it could be that low melatonin causes diabetes, but it

Read the full article →

Protein EPAC2 Plays Major Role In Development Of Type 2 Diabetes

April 13, 2013

A team of researchers at the Johns Hopkins Children's Center has found that a protein long believed to have a minor role in type 2 diabetes is, in fact, a central player in the development of the condition that affects nearly 26 million people in the United States alone and counts as one of the [...]

Read the full article →

Safety Alert Over Faulty Diabetes Blood Meters

April 13, 2013

PEOPLE with diabetes have been warned to check if they have a faulty blood glucose meter at home that could give a false reading and delay treatment.

Read the full article →